Select Committee on Science and Technology Appendices to the Minutes of Evidence

Annex C

SIXTH FRAMEWORK PROGRAMME 2002-06

	Types of Activity	Millions of Euros	%
1	FOCUSSING AND INTEGRATING COMMUNITY RESEARCH	13,345	76.3
	THEMATIC PRIORITIES1	11,285	64.5
	LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY FOR HEALTH	2,255	12.9
	—Advanced genomics and its applications for health	1,100	6.3
	—Combating major diseases2	1,155	6.6
	INFORMATION SOCIETY TECHNOLOGIES3	3,625	20.7
	NANOTECHNOLOGIES AND NANOSCIENCES, KNOWLEDGE-BASED MULTIFUNCTIONAL MATERIALS AND NEW PRODUCTION PROCESSES AND DEVICES	1,300	7.4
	AERONAUTICS AND SPACE	1,075	6.1
	FOOD QUALITY AND SAFETY	685	3.9
	SUSTAINABLE DEVELOPMENT, GLOBAL CHANGE AND ECOSYSTEMS	2,120	12.1
	—Sustainable energy systems	810	4.6
	—Sustainable surface transport	610	3.5
	—Global change and ecosystems	700	4.0
	CITIZENS AND GOVERNANCE IN A KNOWLEDGE-BASED SOCIETY	225	1.3
	Specific activities covering a wider field of research	1,300	7.4
	—Supporting policies and anticipating scientific and technological needs	555	3.2
	—Horizontal research activities involving SMEs	430	2.5
	—Specific measures in support of international co-operation4	315	1.8
	Non-nuclear activities of the Joint Research Centre	760	4.3
2	STRUCTURING THE EUROPEAN RESEARCH AREA	2,605	14.9
	Research and innovation	290	1.7
	Human resources and mobility	1,580	9.0
	Research infrastructures5	655	3.7
	Science and society	80	0.5
3	STRENGTHENING THE FOUNDATIONS OF THE EUROPEAN RESEARCH AREA	320	1.8
	Support for the co-ordination of activities	270	1.5
	Support for the coherent development of policies	50	0.3
4	RESEARCH AND TRAINING IN THE NUCLEAR FIELD (EURATOM TREATY)	1,230	7.0
	Priority thematic fields of research	890	5.0
	—Controlled thermonuclear fusion	750	4.3
	—Management of radioactive waste	90	0.5
	—Radioprotection	50	0.3
	Other activities in the field of technologies and nuclear safety	50	0.3
	Activities of the Joint Research Centre	290	1.7
	TOTAL	17,500	100

  1  Of which at least 15 per cent aimed for SMEs.

  2  Including up to EUR 400 million for cancer-related research.

  3  Including up to 100 million for the continued development of Géant and GRID.

  4  This amount of EUR 315 million will fund specific measures in support of international cooperation involving developing countries, Mediterranean countries including the Western Balkans, and Russia and the Newly Independent States (NIS). Another EUR 285 million is earmarked to finance the participation of third country organisations in the `Thematic Priorities' and in the `Specific activities covering a wider field of research', thus bringing the total amount devoted to international cooperation to EUR 600 million. Additional resources will be available under section 2.2 `Human resources and mobility' to fund research training for third country researchers in Europe.

  5  Including up to EUR 200 million for continuation of the Géant and GRID projects.

---

---

Prepared 6 November 2002